欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/1076/004
药品名称
Zamil
活性成分
olanzapine 10.0 mg
剂型
Tablet
上市许可持有人
Mylan Pharmaceuticals S.L. Calle Plom 2-1, Planta 5 Barcelona Spain
参考成员国 - 产品名称
Denmark (DK)
Zamil
互认成员国 - 产品名称
许可日期
2007/08/31
最近更新日期
2021/03/15
药物ATC编码
N05AH03 olanzapine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
common_combined_tab_dk1076_v032_clean
Date of last change:2024/09/06
Final PL
|
Final PIL orodispersible tablets
Date of last change:2024/09/06
Final PL
|
Final PIL tablets
Date of last change:2024/09/06
Final PL
|
Final SmPC orodispersible tablets
Date of last change:2024/09/06
Final PL
|
Final SmPC tablets
Date of last change:2024/09/06
市场状态
Withdrawn(注:已撤市)
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase